CareDox, the US-based developer of a digital platform for paediatric care, completed a $16m series B round on Wednesday that included Wanxiang Healthcare Investments, a subsidiary of auto components producer Wanxiang.
The round was co-led by Venture capital fund 7wire Ventures and AI Life Sciences Investments, an affiliate of conglomerate Access Industries, and included VC group Digitalis Ventures, VC firm Prolog Ventures and early-stage investment fund StartUp Health.
CareDox has created a cloud-based platform it supplies to schools, allowing students’ medical charts, medication and immunisations to be tracked and enabling parents to be kept up to date with information on health events.
Avi Naider, manager of AI Life Sciences Investments, said: “The services provided by CareDox make sense; go where the kids are – schools.
“By connecting schools, parents and providers through the CareDox platform we can improve student healthcare outcomes. We are proud to participate in this financing and facilitate CareDox’s mission to materially improve the quality of paediatric health in America.”
Digitalis had previously led CareDox’s $6.4m series A round in March 2017, investing alongside Prolog Ventures, First Round Capital, Giza Venture Capital and Texo Ventures.
The company has now raised a total of $27.8m in equity funding in addition to $1.5m in venture debt supplied by Western Technology Investment in 2016.